UCM Technologies Inc. Presented a Revolutionary Three-Biomarker Signature Test for Early Stage (Stages I-II) Detection of Non-Small Cell Lung Cancer at the American Society of Clinical Oncology (ASCO) 2023 Meeting in Chicago IL
CHICAGO, IL / ACCESSWIRE / June 4, 2023 / UCM Technologies has utilized a breakthrough combination of biomarkers (CA-62, CEA and CYFRA 21-1) to detect...
New Experimental Treatment for Prostate Cancer Revealed at AACR
Evexomostat (SDX-7320) shows potent anti-tumor effects in pre-clinical models of prostate cancer, including castration-resistant. New research data to be presented at AACR 2023 in Orlando,...
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications
Criterium, Inc., a full-service Contract Research Organization (CRO), is pleased to announce AURIC (Academic Urology Research Investigators Consortium) — a newly formed GU Oncology Consortium. The...